Key Market Indicators
### Spanish Antiinfective Medicine Market to Hit $2.34 Billion by 2028 The Spanish antiinfective medicine market is projected to grow from $2 billion in 2023 to $2.34 billion by 2028, marking an average annual growth rate of 2.5%. However, this growth comes after a period of decline, as the market had been shrinking by 1.9% year on year since 2009. In 2023, Spain was the second-largest market for antiinfective medicines, trailing behind Italy, which also recorded sales of $2 billion. Following Spain in the rankings were Croatia and Australia, occupying the third and fourth positions respectively. ### Decline in Spanish Antibiotics Export In terms of antibiotics export, Spain is expected to see a decrease. Exports are anticipated to fall from $374.8 million in 2023 to approximately $365.75 million by 2028, representing an annual decline of 0.5%. This continues a longstanding trend; since 1994, Spanish antibiotic exports have decreased by an average of 0.8% per year. ### Rise in Spanish Antibiotics Import Conversely, Spain’s import of antibiotics is on the rise. By 2028, imports are expected to reach around $407.6 million, up from $376 million in 2023. This reflects an average annual growth rate of 1.2%. Spanish demand for antibiotics has been increasing consistently since 1994, with an average yearly growth rate of 1.5%. These figures highlight shifting dynamics in Spain's pharmaceutical trade, underscoring a growing domestic demand for antibiotics even as export volumes continue to decline.
